Evidence map›Paper›PMID 39320022›Full record

ReviewPest management science2025

Discovery, research and development of axalion® active insecticide: dimpropyridaz

Desirée Hodges

Abstract readReview
In one paragraph

Review in Pest management science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Desirée HodgesGlobal Insecticides Research and Development - Agronomy, BASF Corporation, Research Triangle Park, NC, USA.ORCID https://orcid.org/0009-0000-2755-4108

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dimpropyridaz is a novel insecticide active ingredient (a.i.) for the control of piercing and sucking pests. The discovery of dimpropyridaz included the synthesis of thousands of compound analogs which were investigated for their potential efficacy and registrability. Dimpropyridaz is the sole representative of the pyridazine pyrazolecarboxamide class, Insecticide Resistance Action Committee (IRAC) Group 36. The novel mode of action is characterized by disrupting the function of an insect's chordotonal organs in a way that is distinctly different from IRAC Groups 9 and 29. Dimpropyridaz demonstrates translaminar and systemic effects as well as high selectivity, providing both application flexibility and, when applied according to the label, beneficial organism, and environmental compatibility. Dimpropyridaz, powered formulations will be available in select markets, covering a broad range of vegetable, fruit, row crop, and ornamental production segments. Dimpropyridaz also has commercial registered name: Axalion Active. This review will focus on a broad outline of the chemical preparation, regulatory overview, and select biological performance and represents a summary of the information shared during the invited lecture at the 15th IUPAC (International Union of Pure and Applied Chemistry) International Congress of Crop Protection Chemistry held in New Delhi, India in March 2023. © 2024 BASF. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

Indexed as

Insect ControlInsecticidesPyrazolesPyridazinesAnimalsDrug DiscoveryInsecticidesPyrazolesPyridazineschordotonal organsdimpropyridazIRAC Group 36residual activitysystemicity

Identifiers

PMID39320022
PMCPMC11981975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.